A brain aneurysm is a weakened, balloon-like bulge in one of the arteries that supply blood to the brain. It usually grows silently, causes no symptoms, and a person may live for years completely unaware of its presence. But when it ruptures, the picture changes dramatically: bleeding occurs inside the skull (subarachnoid hemorrhage), and the consequences are often devastating. Approximately 50% of patients with a ruptured brain aneurysm die, 25% are left with permanent disability, and only 25% recover well.

Brain aneurysm screening is an imaging-based check performed on high-risk individuals who have no symptoms, aiming to detect this silent balloon before it ruptures. In neurosurgical practice, screening is carefully reserved for selected individuals based on family history, genetic conditions, or specific risk groups.

Why Isn’t Brain Aneurysm Screening Done for Everyone?

This is one of the most common questions the public asks. “If it’s this dangerous, why isn’t everyone screened?” It’s a natural thought. The answer is this: screening is only meaningful when the benefits outweigh the harms.

In the general population, brain aneurysms occur in about 2-3% of people, and the vast majority of these aneurysms never rupture and remain silent throughout a person’s lifetime. Screening the general population causes net harm, because small aneurysms have a very low annual rupture rate (0.05%), treatment of a detected aneurysm carries its own risks, and the knowledge “there is an aneurysm in my head” creates significant psychological burden.

In other words, screening saves lives when done on the right person, but when done indiscriminately, it can create unnecessary anxiety, unnecessary procedures, and even the risk of stroke. For this reason, neurosurgeons adopt a selective screening approach.

Who Should Get a Brain Aneurysm Screening?

According to current guidelines, the main groups for whom screening is recommended are:

1. Those with a strong family history

In individuals who have two or more first-degree relatives (mother, father, sibling, child) with a ruptured aneurysm (subarachnoid hemorrhage) or an unruptured intracranial aneurysm, the risk of harboring an aneurysm is approximately 8%; this is significantly higher than the 1.8% rate in the general population, and screening provides net benefit in this group. A history of a sibling lost to an aneurysm at a young age (for example, in their 30s or 40s) is considered a strong indicator supporting screening.

If only a single first-degree relative has a history of aneurysm, the decision is more individualized. In individuals with only one first-degree relative with an aneurysm, the likelihood of harboring an aneurysm is approximately 4%, particularly if additional risk factors are present (female sex, smoking, hypertension, age over 50), and screening may be considered.

2. Those with polycystic kidney disease (ADPKD)

Autosomal dominant polycystic kidney disease carries a genetic connective tissue feature that also affects brain vessels. In individuals with ADPKD who also have a family history of brain aneurysm, the risk of harboring an aneurysm rises to 16-23%; for this reason, screening is recommended. Even in individuals with ADPKD but without a family history, the risk is between 6-11%, and screening should be carefully considered.

3. Those with certain genetic conditions

In some rare conditions such as type IV Ehlers-Danlos syndrome, microcephalic osteodysplastic primordial dwarfism (with aneurysm prevalence reaching 52%), coarctation of the aorta (10.3%), or bicuspid aortic valve, the risk of brain aneurysm is significantly elevated and screening becomes appropriate. Marfan syndrome and fibromuscular dysplasia are also among the conditions that affect vascular structure.

4. Individuals previously treated for a brain aneurysm

In patients whose aneurysm has been treated, the risk of developing a new aneurysm over time or having additional aneurysms in remaining vessels is higher than in the general population; these individuals also undergo regular follow-up imaging.

How Is Screening Performed?

Three methods are used for brain aneurysm screening; however, the preferred method for outpatient screening is one that is radiation-free and does not require intravenous contrast.

MR Angiography (MRA) — first choice. MRA is the preferred method for initial screening; it has 95% pooled sensitivity and 89% specificity, and it detects aneurysms larger than 3-5 mm with particularly high accuracy. MRA performed with 3 Tesla MRI machines also improves the detection of smaller aneurysms. In most cases, screening MRA can be performed without contrast (dye); this makes it a safe option. The procedure takes 20-30 minutes, is painless, and involves no radiation.

CT Angiography (CTA). Preferred when MRI cannot be performed (pacemaker, severe claustrophobia, certain metallic implants, etc.). It is fast, but involves radiation and intravenous contrast material.

Digital Subtraction Angiography (DSA). This is the “gold standard” method, performed by inserting a catheter through the groin and advancing it into the vessels; however, it is invasive and carries its own risk of stroke. For this reason, it is not the first choice for screening; it is used when MRA or CTA reveals a suspicious finding or when treatment is being planned.

What Happens After Screening?

• If no aneurysm is found: In individuals with a strong family history, screening is not a one-time procedure. Even if the initial screening is normal, there is a high risk of developing a new aneurysm 5 years later; therefore, repeat screening at regular intervals comes into consideration.
• If a small aneurysm is found (generally <5-7 mm): It is usually not treated immediately. Growth or change in shape is monitored with regularly spaced MRA follow-ups.
• If a large, suspicious, or growing aneurysm is found: The neurosurgery/interventional neuroradiology team is involved. Treatment options fall under two main categories: endovascular procedures performed through the vessels (coiling, flow-diverter stents), or clipping performed via open surgery. The choice depends on the location, shape, and size of the aneurysm, as well as the patient’s overall condition.

What to Know Before Screening

Before recommending screening, neurosurgeons discuss the following topics with the patient: Important considerations include the implications for holding a driver’s or pilot’s license should an aneurysm be detected, information disclosure for life insurance applications, and whether the patient wishes to be informed about “incidental findings” (other notable findings unrelated to aneurysms) that may appear on imaging.

It is also important to emphasize this point: Screening does not 100% rule out every aneurysm. Very small aneurysms can be missed; therefore, in high-risk individuals, follow-up is a continuous process.

Modifiable Risk Factors

The factors that play a role in aneurysm formation and especially in rupture — and that are within the individual’s control — are:

• Smoking (the strongest modifiable risk factor — multiplies the risk of rupture)
• High blood pressure (uncontrolled hypertension increases aneurysm growth and rupture risk)
• Heavy alcohol use
• Stimulant drug use (substances like cocaine and amphetamines cause sudden blood pressure spikes)

Factors such as family history, age, sex, and genetics cannot be changed, but those above can. If you come from a high-risk family, quitting smoking and keeping blood pressure under tight control may offer protection even stronger than what screening itself provides.

Conclusion: When Should You See a Neurosurgeon?

If any of the following situations apply to you, it would be appropriate to discuss the need for screening with a neurosurgeon or neurologist:

• If two or more of your first-degree relatives have a history of brain aneurysm or brain hemorrhage
• If someone in your family was lost to a brain hemorrhage at a young age (under 50)
• If you have polycystic kidney disease
• If you have a connective tissue disease such as Ehlers-Danlos or Marfan syndrome
• If you have previously been treated for a brain aneurysm

It should not be forgotten that brain aneurysm screening is not a “scare test”; it is a tool that saves lives in the right person and creates unnecessary anxiety in the wrong one. For this reason, the decision is always individual and must be made together with an experienced physician.

---

This article is intended for general information purposes only and is not a substitute for medical evaluation. To develop a screening plan for your own situation, please consult a neurosurgery, neurology, or interventional neuroradiology specialist.